Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...
Researchers assessed the prognostic significance of older age and comorbidity burden on overall survival in patients with hepatocellular carcinoma.
10d
Vietnam Investment Review on MSNLion TCR s Liocyx M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV Related Hepatocellular CarcinomaOn 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...
Copyright 2025 The Associated Press. All Rights Reserved. A cat poses for a picture in London, Tuesday, Feb. 4, 2025. (AP Photo/Kirsty Wigglesworth) Scotland’s ...
E-mail: [email protected] Cancer Immunol Res 2025;13:162–70 Current address for T. Kobayashi: Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.
7 Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China Objective Hepatocellular carcinoma (HCC) is heterogeneous, especially in multifocal tumours, ...
inserm.fr Objective Hepatocellular carcinoma (HCC) is the most prevalent primary tumour of the liver. About a third of these tumours presents activating mutations of the β-catenin gene. The molecular ...
Cats have a reputation for aloofness (and flooffiness), but if you and your feline friend aren't bonding, maybe you're just not speaking their language. Never fear – research from 2020 has shown that ...
Tootie’s resounding success at Tassie cat shows hasn’t got to his head, stepping up to the plate when owner was diagnosed with cancer. Now, he’s has a special celebration coming up.
Cancer cells rely on mitophagy under conditions of high oxidative ... stress induction using carbonyl cyanide m-chlorophenyl hydrazone (CCCP, Sigma-Aldrich, Cat. #C2759) for all the cell lines. These ...
Use of pathological response versus RECIST assessment in predicting relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma. Expanded biomarker analysis of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results